BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14734473)

  • 21. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Pookot D; Li LC; Tabatabai ZL; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Int J Cancer; 2005 Aug; 116(2):174-81. PubMed ID: 15800905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients.
    Drobnjak M; Melamed J; Taneja S; Melzer K; Wieczorek R; Levinson B; Zeleniuch-Jacquotte A; Polsky D; Ferrara J; Perez-Soler R; Cordon-Cardo C; Pagano M; Osman I
    Clin Cancer Res; 2003 Jul; 9(7):2613-9. PubMed ID: 12855638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of ethnicity on surgical margins at radical prostatectomy.
    Rabbani F; Yunis LH; Vora K; Eastham JA; Guillonneau B; Scardino PT; Touijer K
    BJU Int; 2009 Oct; 104(7):904-8. PubMed ID: 19389008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy.
    Weprin SA; Parker DC; Jones JD; Kaplan JR; Giusto LL; Mydlo JH; Yu SS; Lee DI; Eun DD; Reese AC
    Clin Genitourin Cancer; 2019 Oct; 17(5):e1054-e1059. PubMed ID: 31303559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
    Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
    Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.
    Moses KA; Paciorek AT; Penson DF; Carroll PR; Master VA
    J Clin Oncol; 2010 Feb; 28(6):1069-74. PubMed ID: 20100957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.
    Zagars GK; Pollack A; Pettaway CA
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):517-23. PubMed ID: 9806509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy.
    Falagario UG; Ratnani P; Lantz A; Jambor I; Dovey Z; Verma A; Treacy PJ; Sobotka S; Martini A; Bashorun H; Ashan M; Wagaskar VG; Lewis S; Cormio L; Carrieri G; Kyprianou N; Mohamed N; Tewari A
    J Urol; 2020 Jul; 204(1):82-90. PubMed ID: 31977261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
    Latini DM; Elkin EP; Cooperberg MR; Sadetsky N; Duchane J; Carroll PR
    Cancer; 2006 Feb; 106(4):789-95. PubMed ID: 16400651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
    J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
    Eastham JA; Kattan MW
    J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of premalignant lesions and carcinoma of the prostate in African-American men.
    Sakr WA; Grignon DJ; Haas GP
    Semin Urol Oncol; 1998 Nov; 16(4):214-20. PubMed ID: 9858328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Korean prostate cancer patients have worse disease characteristics than their American counterparts.
    Kang DI; Chung JI; Ha HK; Min K; Yoon J; Kim W; Seo WI; Kang Pm; Jung SJ; Kim IY
    Asian Pac J Cancer Prev; 2013; 14(11):6913-7. PubMed ID: 24377625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells.
    Tu LC; Yan X; Hood L; Lin B
    Mol Cell Proteomics; 2007 Apr; 6(4):575-88. PubMed ID: 17220478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.
    Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
    J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database.
    Bañez LL; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Freedland SJ
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1208-12. PubMed ID: 19336564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
    Schenk JM; Newcomb LF; Zheng Y; Faino AV; Zhu K; Nyame YA; Brooks JD; Carroll PR; Cooperberg MR; Dash A; Filson CP; Gleave ME; Liss M; Martin FM; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW
    J Urol; 2020 Apr; 203(4):727-733. PubMed ID: 31651227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of race in a predominantly African-American population of patients with low/intermediate risk prostate cancer undergoing radical prostatectomy within an equal access care institution.
    Schreiber D; Levy EB; Schwartz D; Rineer J; Wong A; Rotman M; Weiss JP
    Int Urol Nephrol; 2014 Oct; 46(10):1941-6. PubMed ID: 24969031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.